Search forAll
Found 6,058 results
On Tuesday, March 15th, a massive 51 percent decline in Valeant Pharmaceuticals International, Inc. (VRX) wreaked havoc in the stock market and caused hefty losses to many. VRX started the day...
A Weiss Ratings health trend analysis of over 1,000 insurers indicates that the total cost of health insurance went up from $95 billion in Q1, 2010 to $140 billion in Q3, 2015; that’s an increase...
Berkshire Hathaway (BRKA) is a stock for aspiring investors to covert. Not because Warren Buffett reports that on average he has added 19.2% to the per-share book value of Berkshire Hathaway over...
There are many websites where the gainers and losers are detailed, but not so many that tell you which stocks are on the way up but are not recommended. Weiss Ratings tells you how it is, plain...
We all know how it is. As insecurity and uncertainty grips the men and women of Wall Street the gold barometer swings. UP goes the price of gold and then the fever gains hold and the rest of us...
Among all the hoopla last week was that the market capital value of Google (who calls it Alphabet anyway?) grew beyond Apple’s to become the largest publically traded company in the universe....
Investors are disappointed with the central bankers. They are worried that the Federal Reserve’s forecast for four rate hikes in 2016 is too aggressive and want to see that number cut in half,...
Many experts have been dismissive of bond liquidity fears: Vanguard’s global head of fixed income, Greg Davis, said concerns were “a bit overblown” just a few months ago. Friday’s selloff in...
Last week brought a frightful Dallas Fed Manufacturing report, which showed manufacturing activity in the region contracting for the 10th straight month. Now, I want to point out that...
Here are a few notes on my mid-October market scorecard.  — After rising almost 1% last week, the S&P 500 is now up nearly 8% since the Sept. 29 low. During this period, large-caps have...